Bevacizumab/erlotinibRash and intratumoural haemorrhage: 4 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2013年 / 1451卷 / 1期

关键词：

D O I：

10.1007/s40278-013-2913-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：11 / 11

相关论文

共 50 条

[21] Dabigatran etexilateIntracranial haemorrhage: 4 case reports
[J]. Reactions Weekly, 2017, 1669 (1) : 95 - 95
[22] Anticoagulants/bevacizumabIntraparenchymal haemorrhage: 4 case reports
[J]. Reactions Weekly, 2017, 1653 (1) : 45 - 45
[23] Prasugrel/rivaroxabanVitreous haemorrhage: 4 case reports
[J]. Reactions Weekly, 2016, 1626 (1) : 139 - 139
[24] Heparin/nafamostatRetroperitoneal haemorrhage: 4 case reports
[J]. Reactions Weekly, 2015, 1558 (1) : 98 - 98
[25] AntineoplasticsGastric haemorrhage and perforation: 4 case reports
[J]. Reactions Weekly, 2016, 1586 (1) : 44 - 44
[26] Bevacizumab/ranibizumabSubmacular haemorrhage treated with alteplase in elderly patients: 3 case reports
[J]. Reactions Weekly, 2011, 1360 (1) : 12 - 12
[27] Bevacizumab/pazopanibVarious toxicities: 4 case reports
[J]. Reactions Weekly, 2019, 1758 (1) : 79 - 79
[28] Aflibercept/bevacizumab/ranibizumabEndophthalmitis: 4 case reports
[J]. Reactions Weekly, 2023, 1952 (1) : 34 - 34
[29] Bevacizumab/paclitaxelVarious toxicities: 4 case reports
[J]. Reactions Weekly, 2021, 1844 (1) : 94 - 94
[30] Bevacizumab/irinotecanVarious toxicities: 4 case reports
[J]. Reactions Weekly, 2014, 1532 (1) : 54 - 54

← 1 2 3 4 5 →